306 related articles for article (PubMed ID: 21570468)
21. Peroxisomes, Refsum's disease and the alpha- and omega-oxidation of phytanic acid.
Wanders RJ; Komen JC
Biochem Soc Trans; 2007 Nov; 35(Pt 5):865-9. PubMed ID: 17956234
[TBL] [Abstract][Full Text] [Related]
22. Oxidation of pristanic acid in fibroblasts and its application to the diagnosis of peroxisomal beta-oxidation defects.
Paton BC; Sharp PC; Crane DI; Poulos A
J Clin Invest; 1996 Feb; 97(3):681-8. PubMed ID: 8609223
[TBL] [Abstract][Full Text] [Related]
23. Effects of phytanic acid on the vitamin E status, lipid composition and physical properties of retinal cell membranes: implications for adult Refsum disease.
Young SP; Johnson AW; Muller DP
Clin Sci (Lond); 2001 Dec; 101(6):697-705. PubMed ID: 11724659
[TBL] [Abstract][Full Text] [Related]
24. Long-term in vitro treatment of INS-1 rat pancreatic β-cells by unsaturated free fatty acids protects cells against gluco- and lipotoxicities via activation of GPR40 receptors.
Tuo Y; Feng DD; Wang DF; Sun J; Li SB; Chen C
Clin Exp Pharmacol Physiol; 2012 May; 39(5):423-8. PubMed ID: 22332921
[TBL] [Abstract][Full Text] [Related]
25. Acute stimulation of glucagon secretion by linoleic acid results from GPR40 activation and [Ca2+]i increase in pancreatic islet {alpha}-cells.
Wang L; Zhao Y; Gui B; Fu R; Ma F; Yu J; Qu P; Dong L; Chen C
J Endocrinol; 2011 Aug; 210(2):173-9. PubMed ID: 21565851
[TBL] [Abstract][Full Text] [Related]
26. New insights in peroxisomal beta-oxidation. Implications for human peroxisomal disorders.
Van Veldhoven PP
Verh K Acad Geneeskd Belg; 1998; 60(3):195-214. PubMed ID: 9803880
[TBL] [Abstract][Full Text] [Related]
27. [A long chain fatty acid receptor GPR40 as a novel pain control system].
Nakamoto K; Tokuyama S
Nihon Shinkei Seishin Yakurigaku Zasshi; 2012 Aug; 32(4):233-7. PubMed ID: 23012892
[TBL] [Abstract][Full Text] [Related]
28. Refsum disease: a defect in the alpha-oxidation of phytanic acid in peroxisomes.
Singh I; Pahan K; Singh AK; Barbosa E
J Lipid Res; 1993 Oct; 34(10):1755-64. PubMed ID: 7504046
[TBL] [Abstract][Full Text] [Related]
29. Fatty acid composition of tissues in Refsum's disease (herodopathia atactica polyneuritiformis). Estimation of total phytanic acid accumulation.
Malmendier CL; Jonniaux G; Voet W; Van Den Bergen CJ
Biomedicine; 1974 Nov; 20(6):398-407. PubMed ID: 4141904
[No Abstract] [Full Text] [Related]
30. A study of the cytotoxicity of branched-chain phytanic acid with mitochondria and rat brain astrocytes.
Schönfeld P; Kahlert S; Reiser G
Exp Gerontol; 2006 Jul; 41(7):688-96. PubMed ID: 16616447
[TBL] [Abstract][Full Text] [Related]
31. Pristanic acid and phytanic acid in plasma from patients with peroxisomal disorders: stable isotope dilution analysis with electron capture negative ion mass fragmentography.
ten Brink HJ; Stellaard F; van den Heuvel CM; Kok RM; Schor DS; Wanders RJ; Jakobs C
J Lipid Res; 1992 Jan; 33(1):41-7. PubMed ID: 1372637
[TBL] [Abstract][Full Text] [Related]
32. Serum phytanic and pristanic acid levels and prostate cancer risk in Finnish smokers.
Wright ME; Albanes D; Moser AB; Weinstein SJ; Snyder K; Männistö S; Gann PH
Cancer Med; 2014 Dec; 3(6):1562-9. PubMed ID: 25132681
[TBL] [Abstract][Full Text] [Related]
33. Human very-long-chain acyl-CoA synthetase: cloning, topography, and relevance to branched-chain fatty acid metabolism.
Steinberg SJ; Wang SJ; Kim DG; Mihalik SJ; Watkins PA
Biochem Biophys Res Commun; 1999 Apr; 257(2):615-21. PubMed ID: 10198260
[TBL] [Abstract][Full Text] [Related]
34. Diagnosis of peroxisomal disorders by analysis of phytanic and pristanic acids in stored blood spots collected at neonatal screening.
ten Brink HJ; van den Heuvel CM; Christensen E; Largillière C; Jakobs C
Clin Chem; 1993 Sep; 39(9):1904-6. PubMed ID: 8375069
[TBL] [Abstract][Full Text] [Related]
35. Phytanic acid--an overlooked bioactive fatty acid in dairy fat?
Hellgren LI
Ann N Y Acad Sci; 2010 Mar; 1190():42-9. PubMed ID: 20388135
[TBL] [Abstract][Full Text] [Related]
36. Phytanic acid alpha-oxidation: accumulation of 2-hydroxyphytanic acid and absence of 2-oxophytanic acid in plasma from patients with peroxisomal disorders.
ten Brink HJ; Schor DS; Kok RM; Poll-The BT; Wanders RJ; Jakobs C
J Lipid Res; 1992 Oct; 33(10):1449-57. PubMed ID: 1385561
[TBL] [Abstract][Full Text] [Related]
37. In brain mitochondria the branched-chain fatty acid phytanic acid impairs energy transduction and sensitizes for permeability transition.
Schönfeld P; Kahlert S; Reiser G
Biochem J; 2004 Oct; 383(Pt 1):121-8. PubMed ID: 15198638
[TBL] [Abstract][Full Text] [Related]
38. Phytanic acid and pristanic acid are oxidized by sequential peroxisomal and mitochondrial reactions in cultured fibroblasts.
Verhoeven NM; Roe DS; Kok RM; Wanders RJ; Jakobs C; Roe CR
J Lipid Res; 1998 Jan; 39(1):66-74. PubMed ID: 9469587
[TBL] [Abstract][Full Text] [Related]
39. Mechanism of toxicity of the branched-chain fatty acid phytanic acid, a marker of Refsum disease, in astrocytes involves mitochondrial impairment.
Reiser G; Schönfeld P; Kahlert S
Int J Dev Neurosci; 2006; 24(2-3):113-22. PubMed ID: 16386870
[TBL] [Abstract][Full Text] [Related]
40. Refsum disease diagnostic marker phytanic acid alters the physical state of membrane proteins of liver mitochondria.
Schönfeld P; Struy H
FEBS Lett; 1999 Aug; 457(2):179-83. PubMed ID: 10471774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
